首页> 外文期刊>Oxidative Medicine and Cellular Longevity >Heat Shock Protein 70 Protects the Heart from Ischemia/Reperfusion Injury through Inhibition of p38 MAPK Signaling
【24h】

Heat Shock Protein 70 Protects the Heart from Ischemia/Reperfusion Injury through Inhibition of p38 MAPK Signaling

机译:热休克蛋白70通过抑制P38 MAPK信号传导来保护心脏免受缺血/再灌注损伤

获取原文
           

摘要

Background. Heat shock protein 70 (Hsp70) has been shown to exert cardioprotection. Intracellular calcium ([Ca2+]i) overload induced by p38 mitogen-activated protein kinase (p38 MAPK) activation contributes to cardiac ischemia/reperfusion (I/R) injury. However, whether Hsp70 interacts with p38 MAPK signaling is unclear. Therefore, this study investigated the regulation of p38 MAPK by Hsp70 in I/R-induced cardiac injury. Methods. Neonatal rat cardiomyocytes were subjected to oxygen-glucose deprivation for 6?h followed by 2?h reoxygenation (OGD/R), and rats underwent left anterior artery ligation for 30?min followed by 30?min of reperfusion. The p38 MAPK inhibitor (SB203580), Hsp70 inhibitor (Quercetin), and Hsp70 short hairpin RNA (shRNA) were used prior to OGD/R or I/R. Cell viability, lactate dehydrogenase (LDH) release, serum cardiac troponin I (cTnI), [Ca2+]i levels, cell apoptosis, myocardial infarct size, mRNA level of IL-1β and IL-6, and protein expression of Hsp70, phosphorylated p38 MAPK (p-p38 MAPK), sarcoplasmic/endoplasmic reticulum Ca2+-ATPase2 (SERCA2), phosphorylated signal transducer and activator of transcription3 (p-STAT3), and cleaved caspase3 were assessed. Results. Pretreatment with a p38 MAPK inhibitor, SB203580, significantly attenuated OGD/R-induced cell injury or I/R-induced myocardial injury, as evidenced by improved cell viability and lower LDH release, resulted in lower serum cTnI and myocardial infarct size, alleviation of [Ca2+]i overload and cell apoptosis, inhibition of IL-1β and IL-6, and modulation of protein expressions of p-p38 MAPK, SERCA2, p-STAT3, and cleaved-caspase3. Knockdown of Hsp70 by shRNA exacerbated OGD/R-induced cell injury, which was effectively abolished by SB203580. Moreover, inhibition of Hsp70 by quercetin enhanced I/R-induced myocardial injury, while SB203580 pretreatment reversed the harmful effects caused by quercetin. Conclusions. Inhibition of Hsp70 aggravates [Ca2+]i overload, inflammation, and apoptosis through regulating p38 MAPK signaling during cardiac I/R injury, which may help provide novel insight into cardioprotective strategies.
机译:背景。热休克蛋白70(HSP70)已被证明施加心脏保护。 P38丝裂原活化蛋白激酶(P38MapK)活化诱导的细胞内钙([Ca2 +] I)过载有助于心脏缺血/再灌注(I / R)损伤。但是,HSP70是否与P38 MAPK信令相互作用尚不清楚。因此,本研究调查了HSP70在I / R诱导的心损伤中调节p38 mapk。方法。对新生大鼠心肌细胞进行氧 - 葡萄糖剥夺6μl,然后进行2μlreoxygenation(OGD / R),并且大鼠接受左前动脉连接30≤min,然后再灌注30?min。在OGD / R或I / R之前使用P38 MAPK抑制剂(SB203580),HSP70抑制剂(槲皮素)和HSP70短发夹RNA(SHRNA)。细胞活力,乳酸脱氢酶(LDH)释放,血清心肌肌钙蛋白I(CTNI),[CA2 +] I水平,细胞凋亡,心肌梗塞尺寸,IL-1β和IL-6的mRNA水平,以及HSP70的蛋白表达,磷酸化P38 MAPK(P-P38 MAPK),肌肉/内质网CA2 + -ATPase2(Serca2),磷酸化信号传感器和转录3(P-STAT3)和切割的Caspase3的活化剂。结果。用P38 MAPK抑制剂的预处理,SB203580,显着减弱的OGD / R诱导的细胞损伤或I / R诱导的心肌损伤,如改善的细胞活力和降低LDH释放所证明,导致血清CTNI和心肌梗塞大小降低,减轻了[Ca2 +] I过载和细胞凋亡,IL-1β和IL-6的抑制,以及P-P38 MAPK,Serca2,P-STAT3和切割Caspase3的蛋白质表达的调节。通过ShRNA敲低HSP70加剧了OGD / R诱导的细胞损伤,由SB203580有效地废除。此外,通过槲皮素增强的I / R诱导的心肌损伤抑制HSP70,而SB203580预处理则逆转槲皮素引起的有害影响。结论。通过在心脏I / R损伤期间调节P38 MAPK信号传导,HSP70对HSP70的抑制加剧了[CA2 +] I过载,炎症和细胞凋亡,这可能有助于提供对心脏保护策略的新颖洞察力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号